Picture of Medacta SA logo

MOVE — Medacta SA News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareBalancedMid CapFalling Star

Brief: Medacta FY Adjusted EBITDA Up At EUR 91.5 Million

April 6 (Reuters) - MEDACTA GROUP SA  MOVE.S :
    * FY SALES INCREASED ORGANICALLY BY 13.9% TO EUR 310.6
MILLION
    * FY ADJUSTED EBITDA INCREASED TO EUR 91.5 MILLION,
CORRESPONDING
TO AN ADJUSTED EBITDA MARGIN OF 29.5%.
    * STRONG START INTO 2020 FINANCIAL YEAR PRIOR TO BEGINNING
OF
CORONAVIRUS CRISIS.
    * CONSCIOUS OF COVID-19 RELATED UNCERTAINTIES, MEDACTA
WITHHOLDS
FINANCIAL GUIDANCE FOR 2020. MID AND LONG-TERM FUNDAMENTALS
REMAIN UNCHANGED.
    * BOARD OF DIRECTORS DECIDED NOT TO PROPOSE TO ANNUAL
GENERAL
MEETING ANY DISTRIBUTION OF DIVIDEND FOR 2019 FINANCIAL YEAR.
    * RECOVERY COULD START LATER IN 2020 AND PARTIALLY IN 2021

Source text for Eikon:  ID:nEQ7LhFRMa 
Further company coverage:  MOVE.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Medacta SA

See all news